HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajay Rana Selected Research

Maxepa

10/2010Combinatorial effect of fish oil (Maxepa) and 1alpha,25-dihydroxyvitamin D(3) in the chemoprevention of DMBA-induced mammary carcinogenesis in rats.
8/2010Fish oil regulates cell proliferation, protect DNA damages and decrease HER-2/neu and c-Myc protein expression in rat mammary carcinogenesis.
7/2008Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajay Rana Research Topics

Disease

47Neoplasms (Cancer)
06/2022 - 01/2007
15Carcinogenesis
01/2022 - 01/2007
12Body Weight (Weight, Body)
06/2015 - 01/2007
8Breast Neoplasms (Breast Cancer)
05/2021 - 01/2007
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2021
6Adenocarcinoma
01/2022 - 01/2019
5Hepatocellular Carcinoma (Hepatoma)
07/2022 - 12/2010
4Inflammation (Inflammations)
06/2022 - 01/2013
4Neoplasm Metastasis (Metastasis)
08/2020 - 07/2010
4Mouth Neoplasms (Oral Cancer)
11/2018 - 02/2015
4Parkinson Disease (Parkinson's Disease)
12/2014 - 08/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 10/2007
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2021 - 08/2004
3Squamous Cell Carcinoma of Head and Neck
11/2018 - 02/2015
3Prostatic Neoplasms (Prostate Cancer)
09/2015 - 10/2011
2Carcinoma (Carcinomatosis)
01/2020 - 12/2007
2Reperfusion Injury
02/2016 - 07/2012
2Mitochondrial Diseases (Mitochondrial Disease)
01/2013 - 09/2010
2Acute Kidney Injury (Acute Renal Failure)
07/2012 - 01/2011
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022
1Fistula
06/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2021
1Listeria Meningitis
07/2021
1Crohn Disease (Crohn's Disease)
07/2021

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2008
11Mitogen-Activated Protein Kinase Kinase Kinase 11IBA
10/2021 - 02/2010
10Pharmaceutical PreparationsIBA
01/2021 - 01/2007
9Phosphotransferases (Kinase)IBA
01/2020 - 02/2010
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 05/2009
5Protein Isoforms (Isoforms)IBA
01/2019 - 10/2014
5Troglitazone (Rezulin)FDA Link
01/2018 - 05/2009
5DNA (Deoxyribonucleic Acid)IBA
08/2010 - 01/2007
5VanadiumIBA
10/2008 - 01/2007
4Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2007
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
4CateninsIBA
01/2021 - 10/2011
4LigandsIBA
01/2018 - 05/2009
4Glycogen Synthase KinasesIBA
11/2016 - 08/2004
3CalciumIBA
01/2022 - 01/2011
3GemcitabineFDA Link
01/2022 - 01/2019
3AMP-Activated Protein KinasesIBA
01/2021 - 09/2015
3Mitogen-Activated Protein KinasesIBA
01/2020 - 05/2013
3Cisplatin (Platino)FDA LinkGeneric
11/2018 - 01/2011
3Glycogen Synthase (Synthase I)IBA
02/2018 - 07/2010
3Estrogens (Estrogen)FDA Link
05/2017 - 02/2010
3Glycogen Synthase Kinase 3IBA
11/2016 - 10/2007
3CreatinineIBA
02/2016 - 01/2011
3SodiumIBA
06/2015 - 01/2011
3PPAR gammaIBA
12/2010 - 08/2004
3Fish OilsIBA
10/2010 - 07/2008
3MaxepaIBA
10/2010 - 07/2008
3beta CateninIBA
07/2010 - 08/2004
3MicronutrientsIBA
01/2007 - 01/2007
2Peptides (Polypeptides)IBA
01/2022 - 10/2014
2Protein Kinases (Protein Kinase)IBA
01/2021 - 12/2014
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2021 - 07/2013
2Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2020
2BerberineIBA
01/2021 - 01/2018
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2020 - 09/2013
2p21-Activated KinasesIBA
01/2020 - 01/2019
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2018 - 05/2013
2Estrogen ReceptorsIBA
07/2018 - 02/2010
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2018 - 02/2018
2Messenger RNA (mRNA)IBA
11/2016 - 02/2008
2Mitochondrial Permeability Transition PoreIBA
02/2016 - 01/2011
2Lapatinib (GW572016)FDA Link
01/2016 - 08/2015
2Trastuzumab (Herceptin)FDA Link
01/2016 - 08/2015
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2014 - 02/2008
2CarcinogensIBA
09/2013 - 01/2007
2SynucleinsIBA
01/2013 - 08/2012
2NitrogenIBA
03/2011 - 01/2011
2Hexosaminidases (Hexosaminidase)IBA
03/2011 - 01/2011
2Glutathione (Reduced Glutathione)IBA
03/2011 - 01/2011
2Adenosine Triphosphate (ATP)IBA
03/2011 - 01/2011
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
03/2011 - 01/2011
2Thiobarbituric Acid Reactive SubstancesIBA
03/2011 - 01/2011
2Urea (Carbamide)FDA LinkGeneric
03/2011 - 01/2011
2Cholecalciferol (Vitamin D3)FDA Link
10/2010 - 10/2008
2EmulsionsIBA
10/2010 - 01/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
09/2010 - 08/2004
2Corn Oil (Oil, Corn)IBA
08/2010 - 07/2008
2Glycogen Synthase Kinase 3 betaIBA
07/2010 - 08/2004
2Dimenhydrinate (DMH)FDA LinkGeneric
10/2008 - 02/2008
2DNA AdductsIBA
02/2008 - 01/2007
1nimbolideIBA
10/2022
1Sorafenib (BAY 43-9006)FDA Link
07/2022
1Complement System Proteins (Complement)IBA
06/2022
1Complement C5a (Complement 5a)IBA
06/2022
1Immune Checkpoint ProteinsIBA
01/2022
1Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2022
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2022
1Biological ProductsIBA
10/2021
1Infliximab (Remicade)FDA Link
07/2021

Therapy/Procedure

14Therapeutics
06/2022 - 12/2010
8Immunotherapy
01/2022 - 01/2019
4Drug Therapy (Chemotherapy)
01/2022 - 02/2010
1Aftercare (After-Treatment)
07/2021